You are here:

Home
NICE Guidance
Conditions and diseases
Gynaecological conditions
Endometrial cancers

Endometrial cancers Products

A list of all our products on endometrial cancers

Filter

Product type

Product typeGuidanceQuality standards

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceHealth technology evaluationHealthTech guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Pembrolizumab with chemotherapy for adjuvant treatment of newly diagnosed high-risk endometrial cancer after surgery with curative intent [ID6207]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
5 August 2026
Expected publication date:
TBC